Lactobacillus bloodstream infections genetically related to probiotic use in pediatric hematopoietic cell transplant patients
Authors:
- 28 February 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (3) , 484-487
Abstract
We describe a cluster of 6 pediatric hematopoietic cell transplant recipients with Lactobacillus bacteremia attributed to probiotic use. Lactobacillus isolates cultured from probiotics and patients’ blood were proven to be related using whole-genome sequencing. Clinical studies are needed to evaluate the safety of probiotic use in immunocompromised patients.Keywords
This publication has 8 references indexed in Scilit:
- Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and SaccharomycesFrontiers in Public Health, 2021
- Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literatureBMC Gastroenterology, 2016
- Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over‐the‐counter probiotic formulationsTransplant Infectious Disease, 2016
- Risk and Safety of ProbioticsClinical Infectious Diseases, 2015
- Lactobacillus rhamnosus Meningitis following Recurrent Episodes of Bacteremia in a Child Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJournal of Clinical Microbiology, 2010
- Probiotic use in clinical practice: what are the risks?The American Journal of Clinical Nutrition, 2006
- Possible Role of Catheters in Saccharomyces boulardii FungemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Lactobacillus Bacteremia and Endocarditis: Review of 45 CasesClinical Infectious Diseases, 1997